50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia Podcast Por  arte de portada

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

Escúchala gratis

Ver detalles del espectáculo

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

Todavía no hay opiniones